DOYLE WILLIAM F bought NVCR
March 3, 2026 · Form 4 insider transaction
DOYLE WILLIAM F bought 200,000 shares of NovoCure Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
200,000
Price
$0.00
Total value
N/A
InsiderDOYLE WILLIAM F
RoleOfficer, Director
CompanyNovoCure Limited (NVCR)
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after200,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.